Fortitude Family Office »

Ovid Therapeutics shares owned by Fortitude Family Office

Quarter-by-quarter ownership of Ovid Therapeutics (OVID) shares owned by Fortitude Family Office from 13F filings

Historical chart of Fortitude Family Office investment in Ovid Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Ovid Therapeutics held by Fortitude Family Office consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ovid Therapeutics by Fortitude Family Office

Quarter filed Position value Share count Share price at filing
2026-03-31 $693 312 2.22

More positions owned by Fortitude Family Office

Ishares Core S&p 500 Etf Etf (IVV)
Avantis Total Equity Markets Etf Etf (AVTM)
Vanguard 0-3 Month Treasury Bill Etf Etf (VBIL)
Ishares Core Msci International Developed Markets Etf Etf (IDEV)
Dimensional Inflation-protected Securities Etf Etf (DFIP)
Imgp Dbi Managed Futures Strategy Etf Etf (DBMF)
Apple Stock (AAPL)
Vanguard Ftse Developed Markets Etf Etf (VEA)
Vanguard Mid-cap Etf Etf (VO)
Vanguard S&p 500 Etf Etf (VOO)
Avantis U.s. Large Cap Value Etf Etf (AVLV)
Dimensional Emerging Markets Core Equity 2 Etf Etf (DFEM)
Ishares Core Msci Emerging Markets Etf Etf (IEMG)
Invesco Senior Loan Etf Etf (BKLN)
Avantis International Small Cap Value Etf Etf (AVDV)

View all positions for Fortitude Family Office

Top funds holding Ovid Therapeutics

RA Capital Management
Henderson Group
Affinity Asset Advisors
Adage Capital Partners GP
Balyasny Asset Management
Vanguard Capital Management
ADAR1 Capital Management
Eventide Asset Management
Federated Investors
Vanguard Group
Ikarian Capital
Ally Bridge Group
Saturn V Capital Management
Sphera Funds Management
BlackRock

View all funds holding Ovid Therapeutics